Press-release for stocks for eli lilly and company

entities : Eli lilly and company crawled time : 12:15

save search

Dicerna Announces Results for PHYOX™4, Single-Dose Study of Nedosiran in Primary Hyperoxaluria Type 3 (PH3)
Published: 2021-10-19 (Crawled : 12:15) - biospace.com/
NVO | News | $126.79 1.22% 340K

Health Technology

| 21.11% | O: -0.08% H: 1.66% C: 1.26%
LLY | News | $735.9 0.63% 180K

Health Technology

| 206.02% | O: 0.03% H: 1.46% C: 1.36%
ALNY | $147.93 1.47% 13K

Health Technology

| -28.5% | O: -0.16% H: 1.75% C: 1.48%
results

IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies
Published: 2021-10-05 (Crawled : 12:15) - biospace.com/
FNCTF | News | $11.16 1.13% 0

Communications

| 1.45% | O: -4.27% H: 0.0% C: 0.0%
PPRUF | News | $364.27 850

Consumer Non-Durables

| -48.63% | O: 1.62% H: 2.94% C: 2.94%
PPRUY | News | $36.96 220K

Manufacturing

| -48.75% | O: -0.11% H: 0.04% C: -0.33%
LLY | News | $735.9 0.63% 180K

Health Technology

| 225.25% | O: 0.71% H: 2.7% C: 1.98%

DTx Pharma to Present at the OIS Retina Innovation Showcase
Published: 2021-10-05 (Crawled : 12:15) - biospace.com/
LLY | News | $735.9 0.63% 180K

Health Technology

| 225.25% | O: 0.71% H: 2.7% C: 1.98%
retina presentation pharma

Dicerna Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigational GalXC™ RNAi Therapeutic Candidate for the Treatment of Alcohol Use Disorder
Published: 2021-09-28 (Crawled : 12:15) - biospace.com/
NVO | News | $126.79 1.22% 340K

Health Technology

| 26.42% | O: -2.48% H: 0.0% C: -1.28%
LLY | News | $735.9 0.63% 180K

Health Technology

| 223.03% | O: -0.0% H: 0.0% C: -2.12%
ALNY | $147.93 1.47% 13K

Health Technology

| -24.79% | O: -7.01% H: 2.22% C: -1.77%
alcohol use disorder treatment phase 1 trial

Dicerna Announces New Executive Leadership Appointments
Published: 2021-09-22 (Crawled : 12:15) - biospace.com/
NVO | News | $126.79 1.22% 340K

Health Technology

| 23.08% | O: -0.82% H: 0.74% C: -0.07%
LLY | News | $735.9 0.63% 180K

Health Technology

| 217.73% | O: -0.07% H: 0.45% C: -0.74%
ALNY | $147.93 1.47% 13K

Health Technology

| -20.83% | O: 0.58% H: 0.11% C: -1.62%
AKBA | $1.37 0.74% 270K

Health Technology

| -52.28% | O: -1.05% H: 2.48% C: -0.35%

Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly's RET-Inhibitor in Non-Small Cell Lung Cancer in Japan
Published: 2021-09-10 (Crawled : 12:15) - prnewswire.com
TMO | News | $567.7 3.52% 540K

Health Technology

| -3.59% | O: 0.49% H: 0.71% C: 0.07%
LLY | News | $735.9 0.63% 180K

Health Technology

| 204.72% | O: 0.92% H: 0.7% C: -1.11%
lung cancer test cancer approval diagnostic

Evommune Inc., Completes $83 Million Series A Financing to Advance Development of Unique Chronic Inflammation Pipeline
Published: 2021-09-09 (Crawled : 12:15) - biospace.com/
LLY | News | $735.9 0.63% 180K

Health Technology

| 186.98% | O: -0.61% H: 0.29% C: -5.25%
unique

Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases
Published: 2021-09-01 (Crawled : 12:15) - biospace.com/
LLY | News | $735.9 0.63% 180K

Health Technology

| 183.14% | O: 0.1% H: 0.09% C: -0.44%
RIGL | $1.15 1.77% 49K

Health Technology

| -70.26% | O: -0.26% H: 8.84% C: 8.44%
covid disease phase 2 infectious disease trial

Rigel Pharmaceuticals Provides Update on COVID-19 Program
Published: 2021-08-13 (Crawled : 12:15) - biospace.com/
LLY | News | $735.9 0.63% 180K

Health Technology

| 177.58% | O: 0.2% H: 0.0% C: 0.0%
RIGL | $1.15 1.77% 49K

Health Technology

| -72.64% | O: -16.22% H: 0.0% C: 0.0%
covid covid-19 program

Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update
Published: 2021-08-09 (Crawled : 12:15) - biospace.com/
NVO | News | $126.79 1.22% 340K

Health Technology

| 27.22% | O: 1.64% H: 0.89% C: 0.58%
LLY | News | $735.9 0.63% 180K

Health Technology

| 177.31% | O: 0.33% H: 3.2% C: 0.98%
ALNY | $147.93 1.47% 13K

Health Technology

| -24.39% | O: 0.37% H: 4.18% C: 3.46%
financial results results

Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin
Published: 2021-06-24 (Crawled : 12:15) - prnewswire.com
LLY | News | $735.9 0.63% 180K

Health Technology

| 236.86% | O: 8.21% H: 1.89% C: -0.83%
leo insulin

Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-06-22 (Crawled : 12:15) - biospace.com/
NVO | News | $126.79 1.22% 340K

Health Technology

| 51.55% | O: -0.39% H: 0.27% C: -0.21%
LLY | News | $735.9 0.63% 180K

Health Technology

| 228.44% | O: -0.02% H: 0.44% C: -0.53%
ALNY | $147.93 1.47% 13K

Health Technology

| -14.87% | O: 0.08% H: 1.01% C: 0.9%
disease liver disease treatment phase 2 liver trial

Dicerna Announces Dosing Completion in Nedosiran PHYOX™4 Clinical Trial for Treatment of Primary Hyperoxaluria Type 3
Published: 2021-06-16 (Crawled : 12:15) - biospace.com/
NVO | News | $126.79 1.22% 340K

Health Technology

| 48.11% | O: -0.2% H: 0.49% C: -0.91%
LLY | News | $735.9 0.63% 180K

Health Technology

| 227.19% | O: 0.0% H: 0.37% C: -1.24%
ALNY | $147.93 1.47% 13K

Health Technology

| -12.44% | O: -0.03% H: 1.15% C: 1.11%
treatment trial

EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
GSK | News | $40.795 0.51% 150K

Health Technology

| 4.0% | O: -0.26% H: 0.26% C: -0.21%
LLY | News | $735.9 0.63% 180K

Health Technology

| 266.53% | O: 0.24% H: 0.96% C: -0.06%
VIR | $8.265 2.04% 64K

Health Technology

| -82.06% | O: 1.75% H: 0.13% C: -1.44%
SNY | News | $47.36 0.45% 120K

Health Technology

| -14.37% | O: -0.43% H: 0.2% C: 0.02%
covid treatment positive biotech technology iot ema

Global Active Pharmaceutical Ingredient (API) Market Report 2021-2025: Opportunities in Advancements in API Manufacturing, Growth in the CMOs, & Emergence of Biosimilars Market
Published: 2021-05-10 (Crawled : 12:15) - prnewswire.com
VTRS | News A | $11.3 0.44% 570K

Health Technology

| -20.1% | O: 6.39% H: 3.3% C: 0.4%
PFE | News A | $26.375 0.44% 1.9M

Health Technology

| -33.65% | O: 0.63% H: 1.13% C: 0.08%
NVS | News | $98.17 3.21% 780K

Health Technology

| 7.74% | O: 0.05% H: 0.37% C: -0.02%
GSK | News | $40.795 0.51% 150K

Health Technology

| 5.84% | O: 0.76% H: 0.27% C: -0.28%
LLY | News | $735.9 0.63% 180K

Health Technology

| 274.23% | O: 0.38% H: 0.22% C: -0.72%
BMY | $49.12 -0.04% 170K

Health Technology

| -23.74% | O: 0.31% H: 1.01% C: 0.09%
ALB | News | $111.45 -0.75% 48K

Process Industries

| -30.99% | O: 0.41% H: 1.07% C: -2.39%
SNY | News | $47.36 0.45% 120K

Health Technology

| -10.7% | O: 1.54% H: 0.17% C: -0.32%
cmo growth merge biosimilar

Sixty8 Capital Announces First Close of $20 Million Fund to Support Diverse Founders
Published: 2021-05-10 (Crawled : 12:15) - prnewswire.com
LLY | News | $735.9 0.63% 180K

Health Technology

| 274.23% | O: 0.38% H: 0.22% C: -0.72%

Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors
Published: 2021-05-05 (Crawled : 12:15) - biospace.com/
WFC | $60.92 -0.3% 280K

Finance

| 32.12% | O: 0.42% H: 0.59% C: 0.02%
LLY | News | $735.9 0.63% 180K

Health Technology

| 288.59% | O: 0.24% H: 2.61% C: 2.21%
ABT | News | $107.68 0.57% 69K

Health Technology

| -8.91% | O: 0.22% H: 0.91% C: 0.6%
PCVX | $62.205 0.98% 12K

Health Technology

| 256.48% | O: 3.85% H: 1.81% C: -0.7%
MTCR | $0.5814 -5.14% 84K

Health Technology

| -84.03% | O: 0.82% H: 0.82% C: -2.45%
GILD | $67.55 0.9% 300K

Health Technology

| 2.0% | O: 0.15% H: 1.92% C: 1.17%
bioscience

Lilly to Host Sustainability Webcast to Provide Overview of Environmental, Social and Governance (ESG) Efforts
Published: 2021-04-01 (Crawled : 12:15) - prnewswire.com
LLY | News | $735.9 0.63% 180K

Health Technology

| 291.46% | O: 0.0% H: 0.67% C: -0.85%

Innovent Announced Financial Results for Full Year Ended December 31, 2020 and Corporate Progress
Published: 2021-03-30 (Crawled : 12:15) - prnewswire.com
LLY | News | $735.9 0.63% 180K

Health Technology

| 292.47% | O: -0.43% H: 0.72% C: -0.02%
financial results results

entities : Eli lilly and company crawled time : 12:15

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

entities : Eli lilly and company crawled time : 12:15 save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

entities : Eli lilly and company crawled time : 12:15

save search